Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers
Epithelial ovarian tumors are a group of morphologically and genetically heterogeneous neoplasms. Based on differences in clinical phenotype and genetic background, ovarian neoplasms are classified as low-grade and high-grade tumor. Borderline ovarian tumors represent approximately 10%–20% of all ep...
Saved in:
Main Authors: | Pawel Sadlecki, Pawel Walentowicz, Magdalena Bodnar, Andrzej Marszalek, Marek Grabiec, Malgorzata Walentowicz-Sadlecka |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-05-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317706230 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system
by: Pawel Sadlecki, et al.
Published: (2017-10-01) -
Eosinophilic Cells as a Distinct Morphological Feature in <i>BRAF<sup>V600E</sup></i>-Mutated Ovarian Serous Borderline Tumors
by: Alina Badlaeva, et al.
Published: (2025-06-01) -
BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis
by: Hardingham, Jennifer E., et al.
Published: (2012) -
BRAF V600E Mutated Gene Variant as a Circulating Molecular Marker in Metastatic Melanoma Patients
by: Vallacchi, Viviana, et al.
Published: (2011) -
Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study
by: Clara Mayo de las Casas, et al.
Published: (2025-01-01)